STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells

International Journal of Cancer

Volumn 78, Issue 3, 1998, Pages 326-330

  Zushi, Shinichiro ^a,b   Shinomura, Yasuhisa ^a   Kiyohara, Tatsuya ^a   Miyazaki, Yoshiji ^a   Kondo, Shinya ^a   Sugimachi, Masamitsu ^a   Higashimoto, Yoshifumi ^a   Kanayama, Shuji ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; DIGESTIVE SYSTEM CANCER; GENE ACTIVATION; GENE EXPRESSION; INTESTINE EPITHELIUM; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; RAT; SIGNAL TRANSDUCTION;

ACUTE-PHASE PROTEINS; ANIMALS; BCL-X PROTEIN; CELL LINE; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DNA FRAGMENTATION; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; GENES, RAS; INTESTINAL MUCOSA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION; TYRPHOSTINS;

EID: 0032578721     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981029)78:3<326::AID-IJC12>3.0.CO;2-4     Document Type: Article

References (18)

1. BARNARD, J.A., BEAUCHAMP, R.D., RUSSELL, W.E., DUBOIS, R.N. and COFFEY, R.J., Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastwenterology, 108, 564-580 (1995).
2. Bos, J.L., FEARON, E.R., HAMILTON, S.R., VERLAAN-DE VRIES, M., VAN BOOM, J.H., AN DER EB, A.J. and VOGELSTEIN, B., Prevalence of ras gene mutations in human colorectal cancers. Nature (Lond.), 327, 293-297 (1987).
3. CHIN, YE., KITAGAWA, M., KUIDA, K., FLAVELL, R.A. and Fu, X.-Y., Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. cell. Biol., 17, 5328-5337 (1997).
4. FEARON, E.R. and VOGELSTEIN, B., A genetic model for colorectal tumorigenesis. Cell, 61, 759-767 (1990).
5. FORRESTER, K., ALMOGUERA, C., HAN, K., GRIZZLE, W.W. and PERUCHO, M., Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature (Land.), 327, 298-303 (1987).
6. FUJIO, Y., KUNISADA, K., HIROTA, H., TAKIHARA-YAMAUCHA, K. and KISHIMPTO, T., Signals through gp130 upregulate bcl-x gene expression via: STATl-binding cis-element in cardiac myocytes. J. clin. Invest., 99, 2898-2905 (1997).
7. FUKADA, T., HIBI, M., YAMANAKA, Y., TAKAHASHI-TEZUKA, M., FUJITANI, Y., YAMAGUCHI, T., NAKAJIMA, K. and HIRANO, T., Two signals,arc necessary for cell proliferation induced by a cytokine receptor gp130 : involvement of STAT3 in anti-apoptosis. Immunity, 5, 449-460 (1996).
8. GANGAROSA, L.M., SIZEMORE, N., GRAVES-DEAL, R., OLDHAM, S.M., DER, C.J. and COFFEY, R.J., A raf-independent epidermal growth factor receptor autocrine loop is necessary for ras transformation of rat intestinal epithelial cells. J. Biol. Chem., 272, 18926-18931 (1997).
9. GOUILLEUX-GRUART, V., GOUILLEUX, F., DESAINT, C., CLAISSE, J.F. CAPIOD, J.C, DELOBEL. J., WEBER-NORDT, R., DUSANTER-FOURT, I., DREYFUS, F., GRONER, B. and PRIN. L., STAT-related transcription factors are constitutiveiy activated in peripheral blood cells from acute leukemia patients. Blood, 87, 1692-1697 (1996).
10. HAGUE, A., MOORGHEN, M., HICKS, D., CHAPMAN, M. and PARASKEVA, C., BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene, 9, 3367-3370 (1994).
11. IHLE, J.N., STATs: signal transducers arid activators of transcription. Cell, 84, 331-334 (1996).
12. KAPTELN, A., PAILLARD, V., and SAUNDERS, M., Dominant negative Stat3 mutant inhibits Interleukin-6-induced Jak-STAT signal transduction. J. biol. Chem., 271, 5961-5964 (1996).
13. KRAJEWSKA, M., MOSS, S.F., KRAJEWSKI, S., SONG, K., HOLT, P.R. and REED, J.C., Elevated expression of bcl-X and reduced bak in primary-colorectal adenocarcinomas. Cancer Res., 56, 2422-2427 (1996).
14. LEAMAN, D.W., PISHARODY, S., FLICKINGER, T.W., COMMANE, M.A., SCHLESSINGER, J., KERR, I.M., LEVY, D.E. and STARK, G.R., Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol cell. Biol., 16, 369-375 (1996).
15. LEVITZKI, A. and GAZIT, A., Tyrosine kinase inhibition: an approach to drug development. Science, 267, 1782-1788 (1995).
16. SARTOR, C.I., DZIUBINSKI, M.L., Yu, C.L., JOVE. R. and ETHIER, S.P., Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast dancer cells. Cancer Res., 57, 978-987 (1997).
17. WATSON, C.J. and MILLER, W.R., Elevated levels of menibers of the STAT family of transcription factors in breast carcinoma nuclear extracts. Brit. J. Cancer, 71, 840-844 (1995).
18. ZUSHI, S., SHINOMURA, Y., KIYOHARA, T., MIYAZAKI, Y., TSUTSUI, S., SUGIMACHI, M., HIGASHIMOTO, Y., KANAYAMA, S. and MATSUZAWA, Y., Role of heparin-binding EGF-related peptides in proliferation and apoptosis of activated ras-stimulated intestinal epithelial cells. Int. J. Cancer, 73, 917-923 (1997).